258 related articles for article (PubMed ID: 18350162)
1. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.
Zen K; Liu DQ; Guo YL; Wang C; Shan J; Fang M; Zhang CY; Liu Y
PLoS One; 2008 Mar; 3(3):e1826. PubMed ID: 18350162
[TBL] [Abstract][Full Text] [Related]
2. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion.
Geng Y; Chandrasekaran S; Hsu JW; Gidwani M; Hughes AD; King MR
PLoS One; 2013; 8(1):e54959. PubMed ID: 23372803
[TBL] [Abstract][Full Text] [Related]
4. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
5. Gangliosides expressed on breast cancer cells are E-selectin ligands.
Shirure VS; Henson KA; Schnaar RL; Nimrichter L; Burdick MM
Biochem Biophys Res Commun; 2011 Mar; 406(3):423-9. PubMed ID: 21329670
[TBL] [Abstract][Full Text] [Related]
6. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.
Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; Santos LL; Sackstein R; Videira PA
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2069-2080. PubMed ID: 29777742
[TBL] [Abstract][Full Text] [Related]
7. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells.
Laferriere J; Houle F; Taher MM; Valerie K; Huot J
J Biol Chem; 2001 Sep; 276(36):33762-72. PubMed ID: 11448946
[TBL] [Abstract][Full Text] [Related]
8. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
[TBL] [Abstract][Full Text] [Related]
10. Adhesion of HT-29 colon carcinoma cells to endothelial cells requires sequential events involving E-selectin and integrin beta4.
Laferrière J; Houle F; Huot J
Clin Exp Metastasis; 2004; 21(3):257-64. PubMed ID: 15387376
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
Barthel SR; Wiese GK; Cho J; Opperman MJ; Hays DL; Siddiqui J; Pienta KJ; Furie B; Dimitroff CJ
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19491-6. PubMed ID: 19889975
[TBL] [Abstract][Full Text] [Related]
12. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
Burdick MM; Chu JT; Godar S; Sackstein R
J Biol Chem; 2006 May; 281(20):13899-905. PubMed ID: 16565092
[TBL] [Abstract][Full Text] [Related]
13. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.
Barthel SR; Gavino JD; Wiese GK; Jaynes JM; Siddiqui J; Dimitroff CJ
Glycobiology; 2008 Oct; 18(10):806-17. PubMed ID: 18647941
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation.
Carrascal MA; Silva M; Ramalho JS; Pen C; Martins M; Pascoal C; Amaral C; Serrano I; Oliveira MJ; Sackstein R; Videira PA
Mol Oncol; 2018 May; 12(5):579-593. PubMed ID: 29215790
[TBL] [Abstract][Full Text] [Related]
15. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers.
Tözeren A; Kleinman HK; Grant DS; Morales D; Mercurio AM; Byers SW
Int J Cancer; 1995 Jan; 60(3):426-31. PubMed ID: 7530236
[TBL] [Abstract][Full Text] [Related]
16. Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links.
Wenzel CT; Scher RL; Richtsmeier WJ
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1279-86. PubMed ID: 7576475
[TBL] [Abstract][Full Text] [Related]
17. Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression.
Liu FR; Jiang CG; Li YS; Li JB; Li F
Int J Mol Med; 2011 Apr; 27(4):537-44. PubMed ID: 21327325
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
[TBL] [Abstract][Full Text] [Related]
19. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
Pachón-Peña G; Donnelly C; Ruiz-Cañada C; Katz A; Fernández-Veledo S; Vendrell J; Sackstein R
Stem Cells; 2017 Apr; 35(4):1080-1092. PubMed ID: 27888602
[TBL] [Abstract][Full Text] [Related]
20. Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells.
Thomas SN; Schnaar RL; Konstantopoulos K
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C505-13. PubMed ID: 19118161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
